Table 4.
Outcome | Predictor | Level | b | Odds Ratio |
SE | z | p |
---|---|---|---|---|---|---|---|
Court offers buprenorphine n = 509 courts | Intercept | — | 1.80 | — | 0.45 | 4.03 | <0.001 |
MAT substitutes one drug for another | Court | −0.77 | 0.46 | 0.16 | −4.97 | <0.001 | |
Buprenorphine patient capacity/1k | County | 0.081 | 1.08 | 0.019 | 4.20 | <0.001 | |
Medicaid expansion | State | 0.70 | 2.01 | 0.27 | 2.62 | <0.01 | |
Court offers methadone n = 509 courts | Intercept | — | 0.85 | — | 0.42 | 2.01 | 0.045 |
Court type | Court | −0.051 | 0.95 | 0.26 | −0.20 | 0.84 | |
MAT substitutes one drug for another | Court | −0.61 | 0.54 | 0.14 | −4.48 | <0.001 | |
Methadone providers/100k | County | 0.50 | 1.65 | 0.16 | 3.17 | <0.01 | |
Medicaid expansion | State | 1.05 | 2.86 | 0.29 | 3.62 | <0.001 | |
State mandates types of services | State | −0.55 | 0.58 | 0.26 | −2.08 | 0.038 | |
Court offers naltrexone n = 509 courts | Intercept | — | 1.38 | — | 0.56 | 2.45 | 0.014 |
Court type | Court | 0.60 | 1.83 | 0.30 | 2.00 | 0.045 | |
MAT substitutes one drug for another | Court | −0.33 | 0.72 | 0.15 | −2.15 | 0.031 | |
Naltrexone providers/100k | County | 0.16 | 1.17 | 0.055 | 2.91 | <0.01 | |
Medicaid expansion | State | 0.50 | 1.65 | 0.39 | 1.28 | 0.20 | |
State mandates types of services | State | −0.68 | 0.51 | 0.37 | −1.84 | 0.066 |